Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) reported earnings for its first quarter that Increased, from last year
The company's bottom line totaled RMB444.33 million, or RMB0.27 per share. This compares with RMB375.01 million, or RMB0.21 per share, last year.
The company's revenue for the period fell 1.4% to RMB2.335 billion from RMB2.368 billion last year.
Zhejiang Huahai Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB444.33 Mln. vs. RMB375.01 Mln. last year.-EPS: RMB0.27 vs. RMB0.21 last year.-Revenue: RMB2.335 Bln vs. RMB2.368 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.